Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析

◆英語タイトル:Aequus Pharmaceuticals Inc (AQS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH498090FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS304 finds application in the treatment of neurological disorders, and AQS303 is used for the treatment of treatment of vomiting of pregnancy and nausea. Aequus Pharmaceuticals markets pharmaceutical products such as Vistitan an ophthalmic solution that reduces elevated IOP in patients with ocular hypertension or open angle glaucoma; and Tacrolimus IR finds application in the prevention of acute rejection following solid organ transplantation. The company offers pharmaceutical products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc Key Recent Developments

Apr 07,2021: Apr 06, 2021 Aequus Provides update on Warrant Acceleration
Mar 01,2021: Aequus launches evolve eyedrops to eye care professionals in Canada
Feb 26,2021: Aequus Closes $1 Million Financing
Feb 17,2021: Aequus announces Marc Lustig joining board of directors and making direct equity investment

This comprehensive SWOT profile of Aequus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aequus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Aequus Pharmaceuticals Inc – Key Information
Aequus Pharmaceuticals Inc – Overview
Aequus Pharmaceuticals Inc – Key Employees
Aequus Pharmaceuticals Inc – Key Employee Biographies
Aequus Pharmaceuticals Inc – Key Operational Heads
Aequus Pharmaceuticals Inc – Major Products and Services
Aequus Pharmaceuticals Inc – History
Aequus Pharmaceuticals Inc – Company Statement
Aequus Pharmaceuticals Inc – Locations And Subsidiaries
Aequus Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Aequus Pharmaceuticals Inc – Business Description
Aequus Pharmaceuticals Inc – Corporate Strategy
Aequus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Aequus Pharmaceuticals Inc – Strengths
Aequus Pharmaceuticals Inc – Weaknesses
Aequus Pharmaceuticals Inc – Opportunities
Aequus Pharmaceuticals Inc – Threats
Aequus Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Aequus Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Aequus Pharmaceuticals Inc, Key Information
Aequus Pharmaceuticals Inc, Key Ratios
Aequus Pharmaceuticals Inc, Share Data
Aequus Pharmaceuticals Inc, Major Products and Services
Aequus Pharmaceuticals Inc, History
Aequus Pharmaceuticals Inc, Key Employees
Aequus Pharmaceuticals Inc, Key Employee Biographies
Aequus Pharmaceuticals Inc, Key Operational Heads
Aequus Pharmaceuticals Inc, Other Locations
Aequus Pharmaceuticals Inc, Subsidiaries
Aequus Pharmaceuticals Inc, Key Competitors
Aequus Pharmaceuticals Inc, SWOT Analysis
Aequus Pharmaceuticals Inc, Ratios based on current share price
Aequus Pharmaceuticals Inc, Annual Ratios
Aequus Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Nintendo Co., Ltd.:企業の戦略・SWOT・財務分析
    Nintendo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nintendo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • EVN AG:企業の発電所・SWOT分析2018
    EVN AG - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives) …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • CMA CGM SA:企業の戦略・SWOT・財務情報
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Konecranes Plc:企業の戦略・SWOT・財務分析
    Konecranes Plc - Strategy, SWOT and Corporate Finance Report Summary Konecranes Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cancer Genetics Inc (CGIX):医療機器:M&Aディール及び事業提携情報
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Malayan Banking Berhad:戦略・SWOT・企業財務分析
    Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Adana Cimento Sanayii Tas
    Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report Summary Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Verbundnetz Gas Aktiengesellschaft-石油・ガス分野:企業M&A・提携分析
    Summary Verbundnetz Gas Aktiengesellschaft (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish Central Graben regi …
  • Schmack Biogas GmbH:企業の戦略的SWOT分析
    Schmack Biogas GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Kohl’s Corporation (KSS):企業の財務・戦略的SWOT分析
    Kohl's Corporation (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Didion Milling Inc.:戦略・SWOT・企業財務分析
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Jabil Inc (JBL)-エネルギー分野:企業M&A・提携分析
    Summary Jabil Inc (Jabil) is a provider of electronic manufacturing services and solutions. It offers electronics design, production and product management services. Its service portfolio includes component selection, sourcing and procurement, integrated design and engineering, enclosure services an …
  • Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • ORBCOMM Inc (ORBC):企業の財務・戦略的SWOT分析
    ORBCOMM Inc (ORBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆